Cargando…
Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative study
BACKGROUND: Prescribing approved products for unapproved uses (off-label use) is not uncommon among physicians in certain medical specialties. Available evidence about an off-label use – both supportive and unsupportive – can influence prescribers’ decisions about a drug’s appropriateness for a part...
Autores principales: | Chansky, Melanie C., Price, Simani M., Aikin, Kathryn J., O’Donoghue, Amie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017050/ https://www.ncbi.nlm.nih.gov/pubmed/35439962 http://dx.doi.org/10.1186/s12875-022-01666-2 |
Ejemplares similares
-
Physician Perceptions of the FDA’s Breakthrough Therapy Designation: An Update
por: Paquin, Ryan S, et al.
Publicado: (2022) -
Evaluating Partnerships for Practice Change in the Prevention, Identification, and Treatment of Fetal Alcohol Spectrum Disorders
por: Sapru, Saloni, et al.
Publicado: (2022) -
Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions
por: Sullivan, Helen W, et al.
Publicado: (2018) -
Common Measures to Evaluate Flavored Tobacco Products: Recommendations From the Tobacco Centers for Regulatory Science (TCORS) Flavored Tobacco Products Measurement Subcommittee
por: Bansal-Travers, Maansi, et al.
Publicado: (2022) -
Physician-pharmacist agreement about off-label use of medications in
private clinical settings in Baghdad, Iraq
por: Hussain, Saad A., et al.
Publicado: (2017)